Call for Papers: Special Issue 2017

Tyrosine Kinase

Series Title: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities

The series will cover all aspects related to expression, regulation and function of receptor tyrosine kinases (RTKs), non-receptor tyrosine kinases and other kinases in oncogenic signaling in cancer cells. Other topics of interest relate to targeted therapies, tyrosine kinase inhibitors (TKI), genetic and epigenetic mechanisms of acquired resistance to TKI, clinical trials and pre-clinical studies.  

The journal encourage submission of original research articles and reviews. The deadline for all submission is October 15, 2017. To submit your manuscript, please use our online submission system available here

When finalizing the submission, use the drop-down menu in the 'Additional Information' tab to specify that you are submitting to this special issue.


View all articles

View all articles

Aims and scope

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Read more

Impact Factor

Molecular Cancer has an Impact Factor of 6.204. It is currently ranked at 36 out of 286 (Q1) in the Biochemistry and Molecular Biology category and 31 out of 217 (Q1) in the Oncology category of Journal Citation Reports.